Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Cervical Cancer
- Chemotherapy and Radiotherapy
- Palliative Care
- Neoadjuvant Therapy
- Gynecological Cancers
- Radiation Therapy
- Immunotherapy
- Radiological Techniques and Scans
Abstract
Citation: Clin Oncol. 2019;4(1):1592.DOI: 10.25107/2474-1663.1592
A Rare Case of Splenic Diffuse Red Pulp Small B-Cell Lymphoma: One Case Report and Relevant Literature Review
Yu Wang, Jingying Dai, Mengying Zou, Chuanyan Jiang, Hui Li, Xiaodong Wang and Rong Xiao
Department of Hematology, Chengdu Medical College, China
Department of Hematology, Sichuan Academy of Medical Sciences, China
PDF Full Text Case Report | Open Access
Abstract:
Splenic Diffuse Red Pulp small B-cell Lymphoma (SDRPL) is an indolent lymphoma with low incidence. In the 2016 WHO edition of lymphoid neoplasms, the SDRPL is assorted into the Splenic B-cell Lymphoma/Leukemia Unclassifiable Category. However, because of its low incidence, the understanding of this disease is still insufficient. Moreover, there is no uniform standard for the treatment of this disease, and the evaluation of disease progression and prognosis is still in the exploratory stage. Here, we report a case of SDRPL and review the relevant literature in order to further explore the pathogenesis, molecular-biological characteristics and prognosis of this disease.
Keywords:
CD10; Cyclin D1; SMZL; SDRPL
Cite the Article:
Wang Y, Dai J, Zou M, Jiang C, Li H, Wang X, et al. A Rare Case of Splenic Diffuse Red Pulp Small B-Cell Lymphoma: One Case Report and Relevant Literature Review. Clin Oncol. 2019; 4: 1592.